XTX Topco’s GSK GSK Stock Holding History

XTX Topco’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.85M	Buy	+35,304	New	+$1.87M	0.02%	1178
2026 Q1	–	Sell	-54,270	Closed	-$2.66M	–	4030
2025 Q4	$2.66M	Sell	54,270 -10,613	-16%	-$495K	0.07%	397
2025 Q3	$2.8M	Buy	64,883 +13,604	+27%	+$531K	0.15%	126
2025 Q2	$1.97M	Buy	+51,279	New	+$1.96M	0.08%	342
2025 Q1	–	Sell	-7,140	Closed	-$241K	–	2656
2024 Q4	$241K	Sell	7,140 -41,185	-85%	-$1.48M	0.02%	1401
2024 Q3	$1.98M	Buy	48,325 +19,721	+69%	+$807K	0.14%	149
2024 Q2	$1.1M	Buy	+28,604	New	+$1.2M	0.09%	323
2024 Q1	–	Sell	-22,692	Closed	-$841K	–	2026
2023 Q4	$841K	Buy	22,692 +17,111	+307%	+$614K	0.18%	55
2023 Q3	$202K	Sell	5,581 -2,610	-32%	-$92.6K	0.03%	1012
2023 Q2	$292K	Buy	+8,191	New	+$294K	0.05%	747
2022 Q3	–	Sell	-25,489	Closed	-$1.39M	–	1209
2022 Q2	$1.39M	Buy	+25,489	New	+$1.41M	0.57%	11
2021 Q4	–	Sell	-4,683	Closed	-$224K	–	811
2021 Q3	$224K	Buy	+4,683	New	+$235K	0.08%	455

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

XTX Topco's GSK Position: Q2 2026 in Review

XTX Topco opened a new position in GSK (GSK) in Q2 2026: 35,304 shares worth $1.85M. The stake represents 0.02% of the portfolio and ranks #1178 among its holdings. This is a return to the name: XTX Topco previously reported a position in GSK as recently as Q4 2025.

XTX Topco first reported a position in GSK in Q3 2021 and has held it in 12 quarters since. The position peaked at $2.8M in Q3 2025. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

XTX Topco held 35,304 shares of GSK worth $1.85M as of Q2 2026.
GSK was a new XTX Topco position in Q2 2026.
GSK made up 0.02% of XTX Topco's portfolio in Q2 2026, its #1178 holding.
XTX Topco first reported a position in GSK in Q3 2021 and has held it in 12 quarters since.
XTX Topco's GSK position peaked at $2.8M in Q3 2025.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.